Stabilise membrane proteins

By External Press Release Author
Tuesday, 16 September, 2008


The new MembraneMax Protein Expression Kits allow researchers to rapidly produce milligrams of soluble membrane proteins that are exceptionally easy to purify. Over 50 per cent of targets in pharmaceutical drug development are membrane proteins. The MembraneMax technology uses nanolipoprotein disks to capture, fold and stabilise membrane proteins produced in a cell-free protein expression system. In initial performance testing, over 30 human membrane proteins were expressed at >0.1mg/ml in soluble form using the new kits. MembraneMax Protein Expression Kits will be a welcome addition to the tools available to membrane protein researchers struggling to understand the detailed molecular structure and function of this therapeutically important class of proteins. Invitrogen Tel: 1800 331 627 www.invitrogen.com/membranemax

Related Articles

The last mile of life sciences innovation

How do we translate technological possibility into meaningful real-world impact?

Machine learning uncovers patterns in DNA methylation

A new machine-learning method identifies differentially methylated DNA regions without sample...

HRT linked to lower dementia risk in some women

Hormone replacement therapy may reduce the risk of dementia — particularly for certain...


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd